{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:17:31Z","timestamp":1792473451106,"version":"4.5.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T00:00:00Z","timestamp":1440460800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1038\/nrendo.2015.139","type":"journal-article","created":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T05:45:08Z","timestamp":1440481508000},"page":"712-724","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":259,"title":["PTH receptor-1 signalling\u2014mechanistic insights and therapeutic prospects"],"prefix":"10.1038","volume":"11","author":[{"given":"Ross W.","family":"Cheloha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel H.","family":"Gellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Vilardaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Gardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,25]]},"reference":[{"key":"BFnrendo2015139_CR1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1210\/endo.133.2.8393771","volume":"133","author":"P Urena","year":"1993","unstructured":"Urena, P. et al. Parathyroid hormone (PTH)\/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues. Endocrinology 133, 617\u2013623 (1993).","journal-title":"Endocrinology"},{"key":"BFnrendo2015139_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00018-010-0465-9","volume":"68","author":"JP Vilardaga","year":"2011","unstructured":"Vilardaga, J. P., Romero, G., Friedman, P. A. & Gardella, T. J. Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm. Cell. Mol. Life Sci. 68, 1\u201313 (2011).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFnrendo2015139_CR3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11914-008-0013-9","volume":"6","author":"S Kousteni","year":"2008","unstructured":"Kousteni, S. & Bilezikian, J. P. The cell biology of parathyroid hormone in osteoblasts. Curr. Osteoporos. Rep. 6, 72\u201376 (2008).","journal-title":"Curr. Osteoporos. Rep."},{"key":"BFnrendo2015139_CR4","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bone.2007.03.017","volume":"40","author":"RL Jilka","year":"2007","unstructured":"Jilka, R. L. Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 40, 1434\u20131446 (2007).","journal-title":"Bone"},{"key":"BFnrendo2015139_CR5","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2215\/CJN.09750913","volume":"10","author":"J Blaine","year":"2015","unstructured":"Blaine, J., Chonchol, M. & Levi, M. Renal control of calcium, phosphate, and magnesium homeostasis. Clin. J. Am. Soc. Nephrol. 10, 1257\u20131272 (2015).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrendo2015139_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/mend.16.1.0760","volume":"16","author":"HA Tawfeek","year":"2002","unstructured":"Tawfeek, H. A., Qian, F. & Abou-Samra, A. B. Phosphorylation of the receptor for PTH and PTHrP is required for internalization and regulates receptor signaling. Mol. Endocrinol. 16, 1\u201313 (2002).","journal-title":"Mol. Endocrinol."},{"key":"BFnrendo2015139_CR7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0167-4889(93)90139-G","volume":"1179","author":"MJ Lohse","year":"1993","unstructured":"Lohse, M. J. Molecular mechanisms of membrane-receptor desensitization. Biochim. Biophys. Acta 1179, 171\u2013188 (1993).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrendo2015139_CR8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1152\/physrev.1991.71.2.371","volume":"71","author":"EM Brown","year":"1991","unstructured":"Brown, E. M. Extracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers. Physiol. Rev. 71, 371\u2013411 (1991).","journal-title":"Physiol. Rev."},{"key":"BFnrendo2015139_CR9","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1152\/physrev.1984.64.3.985","volume":"64","author":"JF Habener","year":"1984","unstructured":"Habener, J. F., Rosenblatt, M. & Potts, J. T. Parathyroid hormone: biochemical aspects of biosynthesis, secretion, action, and metabolism. Physiol. Rev. 64, 985\u20131053 (1984).","journal-title":"Physiol. Rev."},{"key":"BFnrendo2015139_CR10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1124\/jpet.112.199752","volume":"345","author":"ME Cupp","year":"2013","unstructured":"Cupp, M. E., Nayak, S. K., Adem, A. S. & Thomsen, W. J. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways. J. Pharmacol. Exp. Ther. 345, 404\u2013418 (2013).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnrendo2015139_CR11","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1210\/me.2005-0349","volume":"20","author":"T Dean","year":"2006","unstructured":"Dean, T. et al. Mechanisms of ligand binding to the PTH\/PTHrP receptor: selectivity of a modified PTH(1\u201315) radioligand for G\u03b1S-coupled receptor conformations. Mol. Endocrinol. 20, 931\u2013942 (2006).","journal-title":"Mol. Endocrinol."},{"key":"BFnrendo2015139_CR12","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1210\/jc.2002-020773","volume":"88","author":"MJ Horwitz","year":"2003","unstructured":"Horwitz, M. J. et al. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1\u201336) [HPTHrP-(1\u201336)] versus HPTH-(1\u201334) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers. J. Clin. Endocrinol. Metab. 88, 1603\u20131609 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2015139_CR13","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1073\/pnas.89.7.2732","volume":"89","author":"AB Abousamra","year":"1992","unstructured":"Abousamra, A. B. et al. Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. Proc. Natl Acad. Sci. USA 89, 2732\u20132736 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo2015139_CR14","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1210\/en.2004-1283","volume":"146","author":"AT Singh","year":"2005","unstructured":"Singh, A. T., Gilchrist, A., Voyno-Yasenetskaya, T., Radeff-Huang, J. M. & Stern, P. H. G\u03b112\/G\u03b113 subunits of heterotrimeric G proteins mediate parathyroid hormone activation of phospholipase D in UMR-106 osteoblastic cells. Endocrinology 146, 2171\u20132175 (2005).","journal-title":"Endocrinology"},{"key":"BFnrendo2015139_CR15","doi-asserted-by":"crossref","first-page":"11281","DOI":"10.1074\/jbc.M413393200","volume":"280","author":"CA Syme","year":"2005","unstructured":"Syme, C. A., Friedman, P. A. & Bisello, A. Parathyroid hormone receptor trafficking contributes to the activation of extracellular signal-regulated kinases but is not required for regulation of cAMP signaling. J. Biol. Chem. 280, 11281\u201311288 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo2015139_CR16","doi-asserted-by":"crossref","first-page":"10856","DOI":"10.1074\/jbc.M513380200","volume":"281","author":"D Gesty-Palmer","year":"2006","unstructured":"Gesty-Palmer, D. et al. Distinct \u03b2-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1\/2 activation. J. Biol. Chem. 281, 10856\u201310864 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo2015139_CR17","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1210\/en.2004-1262","volume":"146","author":"P Divieti","year":"2005","unstructured":"Divieti, P., Geller, A. I., Suliman, G., Juppner, H. & Bringhurst, F. R. Receptors specific for the carboxyl-terminal region of parathyroid hormone on bone-derived cells: determinants of ligand binding and bioactivity. Endocrinology 146, 1863\u20131870 (2005).","journal-title":"Endocrinology"},{"key":"BFnrendo2015139_CR18","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1096\/fj.09-147033","volume":"24","author":"RE Toribio","year":"2010","unstructured":"Toribio, R. E. et al. The midregion, nuclear localization sequence, and C terminus of PTHrP regulate skeletal development, hematopoiesis, and survival in mice. FASEB J. 24, 1947\u20131957 (2010).","journal-title":"FASEB J."},{"key":"BFnrendo2015139_CR19","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1210\/endo.142.9.8388","volume":"142","author":"F de Miguel","year":"2001","unstructured":"de Miguel, F. et al. The C-terminal region of PTHrP, in addition to the nuclear localization signal, is essential for the intracrine stimulation of proliferation in vascular smooth muscle cells. Endocrinology 142, 4096\u20134105 (2001).","journal-title":"Endocrinology"},{"key":"BFnrendo2015139_CR20","doi-asserted-by":"crossref","first-page":"20309","DOI":"10.1073\/pnas.0805690105","volume":"105","author":"D Miao","year":"2008","unstructured":"Miao, D. et al. Severe growth retardation and early lethality in mice lacking the nuclear localization sequence and C-terminus of PTH-related protein. Proc. Natl Acad. Sci. USA 105, 20309\u201320314 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo2015139_CR21","doi-asserted-by":"crossref","first-page":"26469","DOI":"10.1074\/jbc.271.43.26469","volume":"271","author":"C Bergwitz","year":"1996","unstructured":"Bergwitz, C. et al. Full activation of chimeric receptors by hybrids between parathyroid hormone and calcitonin. Evidence for a common pattern of ligand\u2013receptor interaction. J. Biol. Chem. 271, 26469\u201326472 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo2015139_CR22","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1210\/endo.135.4.7523099","volume":"135","author":"C Lee","year":"1994","unstructured":"Lee, C. et al. Role of the extracellular regions of the parathyroid hormone (PTH)\/PTH-related peptide receptor in hormone binding. Endocrinology 135, 1488\u20131495 (1994).","journal-title":"Endocrinology"},{"key":"BFnrendo2015139_CR23","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1210\/endo.135.3.8070362","volume":"135","author":"TJ Gardella","year":"1994","unstructured":"Gardella, T. J. et al. Determinants of [Arg2]PTH-(1\u201334) binding and signaling in the transmembrane region of the parathyroid hormone receptor. Endocrinology 135, 1186\u20131194 (1994).","journal-title":"Endocrinology"},{"key":"BFnrendo2015139_CR24","first-page":"670","volume":"13","author":"MD Luck","year":"1999","unstructured":"Luck, M. D., Carter, P. H. & Gardella, T. J. The (1\u201314) fragment of parathyroid hormone (PTH) activates intact and amino-terminally truncated PTH-1 receptors. Mol. Endocrinol. 13, 670\u2013680 (1999).","journal-title":"Mol. Endocrinol."},{"key":"BFnrendo2015139_CR25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1210\/endo-127-1-83","volume":"127","author":"MP Caulfield","year":"1990","unstructured":"Caulfield, M. P. et al. The bovine renal parathyroid hormone (PTH) receptor has equal affinity for two different amino acid sequences: the receptor-binding domains of PTH and PTH-related protein are located within the 14\u201334 region. Endocrinology 127, 83\u201387 (1990).","journal-title":"Endocrinology"},{"key":"BFnrendo2015139_CR26","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1210\/endo.134.2.8299582","volume":"134","author":"H J\u00fcppner","year":"1994","unstructured":"J\u00fcppner, H. et al. The extracellular amino-terminal region of the parathyroid hormone (PTH)\/PTH-related peptide receptor determines the binding affinity for carboxyl-terminal fragments of PTH-(1\u201334). Endocrinology 134, 879\u2013884 (1994).","journal-title":"Endocrinology"},{"key":"BFnrendo2015139_CR27","doi-asserted-by":"crossref","first-page":"19456","DOI":"10.1074\/jbc.M001596200","volume":"275","author":"M Shimizu","year":"2000","unstructured":"Shimizu, M., Carter, P. & Gardella, T. Autoactivation of type 1 parathyroid hormone receptors containing a tethered ligand. J. Biol. Chem. 275, 19456\u201319460 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo2015139_CR28","doi-asserted-by":"crossref","first-page":"16084","DOI":"10.1073\/pnas.0503942102","volume":"102","author":"M Castro","year":"2005","unstructured":"Castro, M., Nikolaev, V. O., Palm, D., Lohse, M. J. & Vilardaga, J. P. Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism. Proc. Natl Acad. Sci. USA 102, 16084\u201316089 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo2015139_CR29","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.0801027105","volume":"105","author":"AA Pioszak","year":"2008","unstructured":"Pioszak, A. A. & Xu, H. E. Molecular recognition of parathyroid hormone by its G protein-coupled receptor. Proc. Natl Acad. Sci. USA 105, 5034\u20135039 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo2015139_CR30","doi-asserted-by":"crossref","first-page":"28382","DOI":"10.1074\/jbc.M109.022905","volume":"284","author":"AA Pioszak","year":"2009","unstructured":"Pioszak, A. A., Parker, N. R., Gardella, T. J. & Xu, H. E. Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides. J. Biol. Chem. 284, 28382\u201328391 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo2015139_CR31","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nature12393","volume":"499","author":"FY Siu","year":"2013","unstructured":"Siu, F. Y. et al. Structure of the human glucagon class B G-protein-coupled receptor. Nature 499, 444\u2013449 (2013).","journal-title":"Nature"},{"key":"BFnrendo2015139_CR32","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nature12357","volume":"499","author":"K Hollenstein","year":"2013","unstructured":"Hollenstein, K. et al. Structure of class B GPCR corticotropin-releasing factor receptor 1. Nature 499, 438\u2013443 (2013).","journal-title":"Nature"},{"key":"BFnrendo2015139_CR33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tips.2013.11.001","volume":"35","author":"K Hollenstein","year":"2014","unstructured":"Hollenstein, K. et al. Insights into the structure of class B GPCRs. Trends Pharmacol. Sci. 35, 12\u201322 (2014).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnrendo2015139_CR34","doi-asserted-by":"crossref","first-page":"21836","DOI":"10.1074\/jbc.M909861199","volume":"275","author":"M Shimizu","year":"2000","unstructured":"Shimizu, M., Potts, J. J. & Gardella, T. Minimization of parathyroid hormone: novel amino-terminal parathyroid hormone fragments with enhanced potency in activating the type-1 parathyroid hormone receptor. J. Biol. Chem. 275, 21836\u201321843 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo2015139_CR35","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1016\/S0021-9258(19)41611-6","volume":"250","author":"D Goltzman","year":"1975","unstructured":"Goltzman, D., Peytremann, A., Callahan, E., Tregear, G. W. & Potts, J. T. Jr. Analysis of the requirements for parathyroid hormone action in renal membranes with the use of inhibiting analogues. J. Biol. Chem. 250, 3199\u20133203 (1975).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo2015139_CR36","doi-asserted-by":"crossref","first-page":"7557","DOI":"10.1073\/pnas.83.19.7557","volume":"83","author":"SH Doppelt","year":"1986","unstructured":"Doppelt, S. H. et al. Inhibition of the in vivo parathyroid hormone-mediated calcemic response in rats by a synthetic hormone antagonist. Proc. Natl Acad. Sci. USA 83, 7557\u20137560 (1986).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo2015139_CR37","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1021\/bi00458a032","volume":"29","author":"M Chorev","year":"1990","unstructured":"Chorev, M. et al. Modifications of position 12 in parathyroid hormone and parathyroid hormone related protein: toward the design of highly potent antagonists. Biochemistry 29, 1580\u20131586 (1990).","journal-title":"Biochemistry"},{"key":"BFnrendo2015139_CR38","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1210\/endo.137.9.8756569","volume":"137","author":"TJ Gardella","year":"1996","unstructured":"Gardella, T. J. et al. Inverse agonism of amino-terminally truncated parathyroid hormone (PTH) and PTH-related peptide (PThrP) analogs revealed with constitutively active mutant PTH\/PTHrP receptors. Endocrinology 137, 3936\u20133941 (1996).","journal-title":"Endocrinology"},{"key":"BFnrendo2015139_CR39","doi-asserted-by":"crossref","first-page":"38524","DOI":"10.1074\/jbc.M202544200","volume":"277","author":"A Bisello","year":"2002","unstructured":"Bisello, A. et al. Selective ligand-induced stabilization of active and desensitized parathyroid hormone type 1 receptor conformations. J. Biol. Chem. 277, 38524\u201338530 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo2015139_CR40","doi-asserted-by":"crossref","first-page":"13453","DOI":"10.1021\/bi990437n","volume":"38","author":"H Takasu","year":"1999","unstructured":"Takasu, H., Gardella, T. J., Luck, M. D., Potts, J. T. & Bringhurst, F. R. Amino-terminal modifications of human parathyroid hormone (PTH) selectively alter phospholipase C signaling via the type 1 PTH receptor: implications for design of signal-specific PTH ligands. Biochemistry 38, 13453\u201313460 (1999).","journal-title":"Biochemistry"},{"key":"BFnrendo2015139_CR41","doi-asserted-by":"crossref","first-page":"1ra1","DOI":"10.1126\/scitranslmed.3000071","volume":"1","author":"D Gesty-Palmer","year":"2009","unstructured":"Gesty-Palmer, D. et al. A \u03b2-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation. Sci. Transl Med. 1, 1ra1 (2009).","journal-title":"Sci. Transl Med."},{"key":"BFnrendo2015139_CR42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ceb.2013.10.008","volume":"27","author":"JW Wisler","year":"2014","unstructured":"Wisler, J. W., Xiao, K., Thomsen, A. R. & Lefkowitz, R. J. Recent developments in biased agonism. Curr. Opin. Cell Biol. 27, 18\u201324 (2014).","journal-title":"Curr. Opin. Cell Biol."},{"key":"BFnrendo2015139_CR43","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cellsig.2012.11.012","volume":"25","author":"MM van der Lee","year":"2013","unstructured":"van der Lee, M. M. et al. \u03b2-arrestin-biased signaling of PTH analogs of the type 1 parathyroid hormone receptor. Cell Signal. 25, 527\u2013538 (2013).","journal-title":"Cell Signal."},{"key":"BFnrendo2015139_CR44","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2174\/138945012798868416","volume":"13","author":"MJ Mahon","year":"2012","unstructured":"Mahon, M. J. The parathyroid hormone receptorsome and the potential for therapeutic intervention. Curr. Drug Targets 13, 116\u2013128 (2012).","journal-title":"Curr. Drug Targets"},{"key":"BFnrendo2015139_CR45","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nature00816","volume":"417","author":"MJ Mahon","year":"2002","unstructured":"Mahon, M. J., Donowitz, M., Yun, C. C. & Segre, G. V. Na+\/H+ exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling. Nature 417, 858\u2013861 (2002).","journal-title":"Nature"},{"key":"BFnrendo2015139_CR46","doi-asserted-by":"crossref","first-page":"26976","DOI":"10.1074\/jbc.M110.147785","volume":"285","author":"B Wang","year":"2010","unstructured":"Wang, B. et al. Na\/H exchanger regulatory factors control parathyroid hormone receptor signaling by facilitating differential activation of G\u03b1 protein subunits. J. Biol. Chem. 285, 26976\u201326986 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo2015139_CR47","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1124\/pr.110.004176","volume":"63","author":"JA Ardura","year":"2011","unstructured":"Ardura, J. A. & Friedman, P. A. Regulation of G protein-coupled receptor function by Na+\/H+ exchange regulatory factors. Pharmacol. Rev. 63, 882\u2013900 (2011).","journal-title":"Pharmacol. Rev."},{"key":"BFnrendo2015139_CR48","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrd3024","volume":"9","author":"S Rajagopal","year":"2010","unstructured":"Rajagopal, S., Rajagopal, K. & Lefkowitz, R. J. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat. Rev. Drug Discov. 9, 373\u2013386 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrendo2015139_CR49","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.tips.2014.04.007","volume":"35","author":"JD Violin","year":"2014","unstructured":"Violin, J. D., Crombie, A. L., Soergel, D. G. & Lark, M. W. Biased ligands at G-protein-coupled receptors: promise and progress. Trends Pharmacol. Sci. 35, 308\u2013316 (2014).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnrendo2015139_CR50","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tips.2012.05.004","volume":"33","author":"JP Vilardaga","year":"2012","unstructured":"Vilardaga, J. P., Gardella, T. J., Wehbi, V. L. & Feinstein, T. N. Non-canonical signaling of the PTH receptor. Trends Pharmacol. Sci. 33, 423\u2013431 (2012).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnrendo2015139_CR51","doi-asserted-by":"crossref","first-page":"e1000172","DOI":"10.1371\/journal.pbio.1000172","volume":"7","author":"D Calebiro","year":"2009","unstructured":"Calebiro, D. et al. Persistent cAMP signals triggered by internalized G-protein-coupled receptors. PLoS Biol. 7, e1000172 (2009).","journal-title":"PLoS Biol."},{"key":"BFnrendo2015139_CR52","doi-asserted-by":"crossref","first-page":"27849","DOI":"10.1074\/jbc.M112.445098","volume":"288","author":"TN Feinstein","year":"2013","unstructured":"Feinstein, T. N. et al. Noncanonical control of vasopressin receptor type 2 signaling by retromer and arrestin. J. Biol. Chem. 288, 27849\u201327860 (2013).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo2015139_CR53","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nature12000","volume":"495","author":"R Irannejad","year":"2013","unstructured":"Irannejad, R. et al. Conformational biosensors reveal GPCR signalling from endosomes. Nature 495, 534\u2013538 (2013).","journal-title":"Nature"},{"key":"BFnrendo2015139_CR54","doi-asserted-by":"crossref","first-page":"e92042","DOI":"10.1371\/journal.pone.0092042","volume":"9","author":"KV Andreassen","year":"2014","unstructured":"Andreassen, K. V. et al. Prolonged calcitonin receptor signaling by salmon, but not human calcitonin, reveals ligand bias. PLoS ONE 9, e92042 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrendo2015139_CR55","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1210\/me.2013-1314","volume":"28","author":"LM Luttrell","year":"2014","unstructured":"Luttrell, L. M. Minireview: more than just a hammer: ligand 'bias' and pharmaceutical discovery. Mol. Endocrinol. 28, 281\u2013294 (2014).","journal-title":"Mol. Endocrinol."},{"key":"BFnrendo2015139_CR56","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/jc.2002-021122","volume":"88","author":"MJ Horwitz","year":"2003","unstructured":"Horwitz, M. J., Tedesco, M. B., Gundberg, C., Garcia-Ocana, A. & Stewart, A. F. Short-term, high dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis. J. Clin. Endocrinol. Metab. 88, 569\u2013575 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2015139_CR57","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1359\/JBMR.050602","volume":"20","author":"MJ Horwitz","year":"2005","unstructured":"Horwitz, M. J. et al. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D. J. Bone Miner. Res. 20, 1792\u20131803 (2005).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrendo2015139_CR58","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1002\/jbmr.1978","volume":"28","author":"MJ Horwitz","year":"2013","unstructured":"Horwitz, M. J. et al. A comparison of parathyroid hormone-related protein (1\u201336) and parathyroid hormone (1\u201334) on markers of bone turnover and bone density in postmenopausal women: the PrOP study. J. Bone Miner. Res. 28, 2266\u20132276 (2013).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrendo2015139_CR59","doi-asserted-by":"crossref","first-page":"7741","DOI":"10.1074\/jbc.M009395200","volume":"276","author":"SR Hoare","year":"2001","unstructured":"Hoare, S. R., Gardella, T. J. & Usdin, T. B. Evaluating the signal transduction mechanism of the parathyroid hormone 1 receptor. Effect of receptor-G-protein interaction on the ligand binding mechanism and receptor conformation. J. Biol. Chem. 276, 7741\u20137753 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo2015139_CR60","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1210\/me.2007-0274","volume":"22","author":"T Dean","year":"2008","unstructured":"Dean, T., Vilardaga, J. P., Potts, J. T. Jr & Gardella, T. J. Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH\/PThrP receptor. Mol. Endocrinol. 22, 156\u2013166 (2008).","journal-title":"Mol. Endocrinol."},{"key":"BFnrendo2015139_CR61","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nchembio.206","volume":"5","author":"S Ferrandon","year":"2009","unstructured":"Ferrandon, S. et al. Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. Nat. Chem. Biol. 5, 734\u2013742 (2009).","journal-title":"Nat. Chem. Biol."},{"key":"BFnrendo2015139_CR62","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1073\/pnas.1301674110","volume":"110","author":"A Maeda","year":"2013","unstructured":"Maeda, A. et al. Critical role of parathyroid hormone (PTH) receptor-1 phosphorylation in regulating acute responses to PTH. Proc. Natl Acad. Sci. USA 110, 5864\u20135869 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo2015139_CR63","doi-asserted-by":"crossref","first-page":"16525","DOI":"10.1073\/pnas.0808750105","volume":"105","author":"M Okazaki","year":"2008","unstructured":"Okazaki, M. et al. Prolonged signaling at the parathyroid hormone receptor by peptide ligands targeted to a specific receptor conformation. Proc. Natl Acad. Sci. USA 105, 16525\u201316530 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo2015139_CR64","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nrd1500","volume":"3","author":"DC Swinney","year":"2004","unstructured":"Swinney, D. C. Biochemical mechanisms of drug action: what does it take for success? Nat. Rev. Drug Discov. 3, 801\u2013808 (2004).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrendo2015139_CR65","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nrd2082","volume":"5","author":"RA Copeland","year":"2006","unstructured":"Copeland, R. A., Pompliano, D. L. & Meek, T. D. Drug-target residence time and its implications for lead optimization. Nat. Rev. Drug Discov. 5, 730\u2013739 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrendo2015139_CR66","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/med.21307","volume":"34","author":"D Guo","year":"2014","unstructured":"Guo, D., Hillger, J. M., Ijzerman, A. P. & Heitman, L. H. Drug-target residence time\u2014a case for G protein-coupled receptors. Med. Res. Rev. 34, 856\u2013892 (2014).","journal-title":"Med. Res. Rev."},{"key":"BFnrendo2015139_CR67","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nchembio.1589","volume":"10","author":"A Gidon","year":"2014","unstructured":"Gidon, A. et al. Endosomal GPCR signaling turned off by negative feedback actions of PKA and V-ATPase. Nat. Chem. Biol. 10, 707\u2013709 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"BFnrendo2015139_CR68","doi-asserted-by":"crossref","first-page":"44826","DOI":"10.1074\/jbc.M308643200","volume":"278","author":"ND Sonawane","year":"2003","unstructured":"Sonawane, N. D., Szoka, F. C. Jr & Verkman, A. S. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine\u2013DNA polyplexes. J. Biol. Chem. 278, 44826\u201344831 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo2015139_CR69","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1056-8719(99)00024-6","volume":"41","author":"SR Hoare","year":"1999","unstructured":"Hoare, S. R. & Usdin, T. B. Quantitative cell membrane-based radioligand binding assays for parathyroid hormone receptors. J. Pharmacol. Toxicol. Methods 41, 83\u201390 (1999).","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"BFnrendo2015139_CR70","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1242\/jcs.115.3.455","volume":"115","author":"LM Luttrell","year":"2002","unstructured":"Luttrell, L. M. & Lefkowitz, R. J. The role of \u03b2-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci. 115, 455\u2013465 (2002).","journal-title":"J. Cell Sci."},{"key":"BFnrendo2015139_CR71","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nchembio.1665","volume":"10","author":"NG Tsvetanova","year":"2014","unstructured":"Tsvetanova, N. G. & von Zastrow, M. Spatial encoding of cyclic AMP signaling specificity by GPCR endocytosis. Nat. Chem. Biol. 10, 1061\u20131065 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"BFnrendo2015139_CR72","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fncel.2014.00350","volume":"8","author":"D Calebiro","year":"2014","unstructured":"Calebiro, D. & Maiellaro, I. cAMP signaling microdomains and their observation by optical methods. Front. Cell. Neurosci. 8, 350 (2014).","journal-title":"Front. Cell. Neurosci."},{"key":"BFnrendo2015139_CR73","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/j.1742-4658.2009.06926.x","volume":"276","author":"GS Baillie","year":"2009","unstructured":"Baillie, G. S. Compartmentalized signalling: spatial regulation of cAMP by the action of compartmentalized phosphodiesterases. FEBS J. 276, 1790\u20131799 (2009).","journal-title":"FEBS J."},{"key":"BFnrendo2015139_CR74","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1074\/jbc.R114.617951","volume":"290","author":"NG Tsvetanova","year":"2015","unstructured":"Tsvetanova, N. G., Irannejad, R. & von Zastrow, M. G protein-coupled receptor (GPCR) signaling via heterotrimeric G. proteins from endosomes. J. Biol. Chem. 290, 6689\u20136696 (2015).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo2015139_CR75","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nchembio.545","volume":"7","author":"TN Feinstein","year":"2011","unstructured":"Feinstein, T. N. et al. Retromer terminates the generation of cAMP by internalized PTH receptors. Nat. Chem. Biol. 7, 278\u2013284 (2011).","journal-title":"Nat. Chem. Biol."},{"key":"BFnrendo2015139_CR76","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrm2748","volume":"10","author":"A Sorkin","year":"2009","unstructured":"Sorkin, A. & von Zastrow, M. Endocytosis and signalling: intertwining molecular networks. Nat. Rev. Mol. Cell Biol. 10, 609\u2013622 (2009).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnrendo2015139_CR77","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/emboj\/18.4.893","volume":"18","author":"R Hoffmann","year":"1999","unstructured":"Hoffmann, R., Baillie, G. S., MacKenzie, S. J., Yarwood, S. J. & Houslay, M. D. The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579. EMBO J. 18, 893\u2013903 (1999).","journal-title":"EMBO J."},{"key":"BFnrendo2015139_CR78","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1073\/pnas.1205756110","volume":"110","author":"VL Wehbi","year":"2013","unstructured":"Wehbi, V. L. et al. Noncanonical GPCR signaling arising from a PTH receptor\u2013arrestin\u2013G\u03b2\u03b3 complex. Proc. Natl Acad. Sci. USA 110, 1530\u20131535 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo2015139_CR79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.cb.01.110185.000245","volume":"1","author":"JL Goldstein","year":"1985","unstructured":"Goldstein, J. L., Brown, M. S., Anderson, R. G., Russell, D. W. & Schneider, W. J. Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Ann. Rev. Cell Biol. 1, 1\u201339 (1985).","journal-title":"Ann. Rev. Cell Biol."},{"key":"BFnrendo2015139_CR80","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nchembio.1611","volume":"10","author":"JP Vilardaga","year":"2014","unstructured":"Vilardaga, J. P., Jean-Alphonse, F. G. & Gardella, T. J. Endosomal generation of cAMP in GPCR signaling. Nat. Chem. Biol. 10, 700\u2013706 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"BFnrendo2015139_CR81","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/B978-0-12-373884-4.00077-X","volume-title":"Principles of Bone Biology","author":"H Juppner","year":"2008","unstructured":"Juppner, H., Schipani, E. & Silve, C. in Principles of Bone Biology, 3rd Edn Vol. 2 (eds Bilezikian, J. P., Raisz, L. G. & Martin, T. J.) 1431\u20131452 (Elsevier, 2008)."},{"key":"BFnrendo2015139_CR82","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1359\/JBMR.051005","volume":"21","author":"XS Chen","year":"2006","unstructured":"Chen, X. S. et al. Initial characterization of PTH-related protein gene-driven LacZ expression in the mouse. J. Bone Miner. Res. 21, 113\u2013123 (2006).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrendo2015139_CR83","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/endo.136.2.7835276","volume":"136","author":"K Lee","year":"1995","unstructured":"Lee, K., Deeds, J. D. & Segre, G. V. Expression of parathyroid hormone-related peptide and its receptor messenger ribonucleic acids during fetal development of rats. Endocrinology 136, 453\u2013463 (1995).","journal-title":"Endocrinology"},{"key":"BFnrendo2015139_CR84","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.1658941","volume":"254","author":"H Juppner","year":"1991","unstructured":"Juppner, H. et al. A G-protein linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254, 1024\u20131026 (1991).","journal-title":"Science"},{"key":"BFnrendo2015139_CR85","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1172\/JCI2918","volume":"102","author":"AS Jobert","year":"1998","unstructured":"Jobert, A. S. et al. Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J. Clin. Invest. 102, 34\u201340 (1998).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo2015139_CR86","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1093\/hmg\/ddn176","volume":"17","author":"A Couvineau","year":"2008","unstructured":"Couvineau, A. et al. PTHR1 mutations associated with Ollier disease result in receptor loss of function. Hum. Mol. Genet. 17, 2766\u20132775 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrendo2015139_CR87","doi-asserted-by":"crossref","first-page":"e74601","DOI":"10.1371\/journal.pone.0074601","volume":"8","author":"L Risom","year":"2013","unstructured":"Risom, L. et al. Identification of six novel PTH1R mutations in families with a history of primary failure of tooth eruption. PLoS ONE 8, e74601 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrendo2015139_CR88","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.7701349","volume":"268","author":"E Schipani","year":"1995","unstructured":"Schipani, E., Kruse, K. & J\u00fcppner, H. A constitutively active mutant PTH\u2013PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268, 98\u2013100 (1995).","journal-title":"Science"},{"key":"BFnrendo2015139_CR89","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1056\/NEJM199609053351004","volume":"335","author":"E Schipani","year":"1996","unstructured":"Schipani, E. et al. Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. N. Engl. J. Med. 335, 708\u2013714 (1996).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2015139_CR90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/ddi001","volume":"14","author":"S Duchatelet","year":"2005","unstructured":"Duchatelet, S., Ostergaard, E., Cortes, D., Lemainque, A. & Julier, C. Recessive mutations in PTHR1 cause contrasting skeletal dysplasias in Eiken and Blomstrand syndromes. Hum. Mol. Genet. 14, 1\u20135 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrendo2015139_CR91","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1210\/endo.142.4.8103","volume":"142","author":"P Carter","year":"2001","unstructured":"Carter, P. et al. Selective and non-selective inverse agonists for constitutively active type-1 parathyroid hormone receptors: evidence for altered receptor conformations. Endocrinology 142, 1534\u20131545 (2001).","journal-title":"Endocrinology"},{"key":"BFnrendo2015139_CR92","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","volume":"374","author":"WD Fraser","year":"2009","unstructured":"Fraser, W. D. Hyperparathyroidism. Lancet 374, 145\u2013158 (2009).","journal-title":"Lancet"},{"key":"BFnrendo2015139_CR93","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","volume":"352","author":"AF Stewart","year":"2005","unstructured":"Stewart, A. F. Clinical practice. Hypercalcemia associated with cancer. N. Engl. J. Med. 352, 373\u2013379 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2015139_CR94","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1172\/JCI113794","volume":"82","author":"SC Kukreja","year":"1988","unstructured":"Kukreja, S. C. et al. Antibodies to parathyroid hormone-related protein lower serum calcium in athymic mouse models of malignancy-associated hypercalcemia due to human tumors. J. Clin. Invest. 82, 1798\u20131802 (1988).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo2015139_CR95","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/j.seminoncol.2003.08.019","volume":"30","author":"K Sato","year":"2003","unstructured":"Sato, K., Onuma, E., Yocum, R. C. & Ogata, E. Treatment of malignancy-associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody. Semin. Oncol. 30, 167\u2013173 (2003).","journal-title":"Semin. Oncol."},{"key":"BFnrendo2015139_CR96","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00774-005-0640-5","volume":"24","author":"H Iguchi","year":"2006","unstructured":"Iguchi, H., Aramaki, Y., Maruta, S. & Takiguchi, S. Effects of anti-parathyroid hormone-related protein monoclonal antibody and osteoprotegerin on PTHrP-producing tumor-induced cachexia in nude mice. J. Bone Miner. Metab. 24, 16\u201319 (2006).","journal-title":"J. Bone Miner. Metab."},{"key":"BFnrendo2015139_CR97","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/jbmr.5650110804","volume":"11","author":"R Dresner-Pollak","year":"1996","unstructured":"Dresner-Pollak, R. et al. Evaluation in vivo of a potent parathyroid hormone antagonist: [Nle8,18, D-Trp12, Tyr34]bPTH(7\u201334)Nh2. J. Bone Miner. Res. 11, 1061\u20131065 (1996).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrendo2015139_CR98","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s002239900367","volume":"61","author":"HN Rosen","year":"1997","unstructured":"Rosen, H. N. et al. The effect of PTH antagonist BIM-44002 on serum calcium and PTH levels in hypercalcemic hyperparathyroid patients. Calcif. Tissue Int. 61, 455\u2013459 (1997).","journal-title":"Calcif. Tissue Int."},{"key":"BFnrendo2015139_CR99","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ajhg.2010.01.023","volume":"86","author":"E Klopocki","year":"2010","unstructured":"Klopocki, E. et al. Deletion and point mutations of PTHLH cause brachydactyly type E. Am. J. Hum. Genet. 86, 434\u2013439 (2010).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrendo2015139_CR100","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMcp0803050","volume":"359","author":"D Shoback","year":"2008","unstructured":"Shoback, D. Clinical Practice. Hypoparathyroidism. N. Engl. J. Med. 359, 391\u2013403 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2015139_CR101","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/BF03346763","volume":"36","author":"NE Cusano","year":"2013","unstructured":"Cusano, N. E., Rubin, M. R., Irani, D., Sliney, J. Jr & Bilezikian, J. P. Use of parathyroid hormone in hypoparathyroidism. J. Endocrinol. Invest. 36, 1121\u20131127 (2013).","journal-title":"J. Endocrinol. Invest."},{"key":"BFnrendo2015139_CR102","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","volume":"1","author":"M Mannstadt","year":"2013","unstructured":"Mannstadt, M. et al. Efficacy and safety of recombinant human parathyroid hormone (1\u201384) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. Lancet Diabetes Endocrinol. 1, 275\u2013283 (2013).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"BFnrendo2015139_CR103","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1210\/jc.2011-1908","volume":"97","author":"KK Winer","year":"2012","unstructured":"Winer, K. K. et al. Synthetic human parathyroid hormone 1\u201334 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism. J. Clin. Endocrinol. Metab. 97, 391\u2013399 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2015139_CR104","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nbt.2920","volume":"32","author":"RW Cheloha","year":"2014","unstructured":"Cheloha, R. W., Maeda, A., Dean, T., Gardella, T. J. & Gellman, S. H. Backbone modification of a polypeptide drug alters duration of action in vivo. Nat. Biotechnol. 32, 653\u2013655 (2014).","journal-title":"Nat. Biotechnol."},{"key":"BFnrendo2015139_CR105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrd3299","volume":"10","author":"M Kawai","year":"2011","unstructured":"Kawai, M., Moedder, U. I., Khosla, S. & Rosen, C. J. Emerging therapeutic opportunities for skeletal restoration. Nat. Rev. Drug Discov. 10, 141\u2013156 (2011).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrendo2015139_CR106","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer, R. M. et al. Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N. Engl. J. Med. 344, 1434\u20131441 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2015139_CR107","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11914-008-0003-y","volume":"6","author":"PD Miller","year":"2008","unstructured":"Miller, P. D. Safety of parathyroid hormone for the treatment of osteoporosis. Curr. Osteoporos. Rep. 6, 12\u201316 (2008).","journal-title":"Curr. Osteoporos. Rep."},{"key":"BFnrendo2015139_CR108","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.bone.2007.02.001","volume":"40","author":"D Yang","year":"2007","unstructured":"Yang, D. et al. Contributions of parathyroid hormone (PTH)\/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone. Bone 40, 1453\u20131461 (2007).","journal-title":"Bone"},{"key":"BFnrendo2015139_CR109","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrendo.2011.108","volume":"7","author":"ME Kraenzlin","year":"2011","unstructured":"Kraenzlin, M. E. & Meier, C. Parathyroid hormone analogues in the treatment of osteoporosis. Nat. Rev. Endocrinol. 7, 647\u2013656 (2011).","journal-title":"Nat. Rev. Endocrinol."},{"key":"BFnrendo2015139_CR110","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1196\/annals.1402.088","volume":"1117","author":"JT Potts","year":"2007","unstructured":"Potts, J. T. & Gardella, T. J. Progress, paradox, and potential: parathyroid hormone research over five decades. Ann. NY Acad. Sci. 1117, 196\u2013208 (2007).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrendo2015139_CR111","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra067395","volume":"357","author":"E Canalis","year":"2007","unstructured":"Canalis, E., Giustina, A. & Bilezikian, J. P. Mechanisms of anabolic therapies for osteoporosis. N. Engl. J. Med. 357, 905\u2013916 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2015139_CR112","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1517\/13543784.2015.973021","volume":"24","author":"SA Polyzos","year":"2015","unstructured":"Polyzos, S. A., Makras, P., Efstathiadou, Z. & Anastasilakis, A. D. Investigational parathyroid hormone receptor analogs for the treatment of osteoporosis. Exp. Opin. Investigat. Drugs 24, 145\u2013157 (2015).","journal-title":"Exp. Opin. Investigat. Drugs"},{"key":"BFnrendo2015139_CR113","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1210\/jc.2009-0233","volume":"95","author":"MJ Horwitz","year":"2010","unstructured":"Horwitz, M. J. et al. Parathyroid hormone-related protein for the treatment of postmenopausal osteoporosis: defining the maximal tolerable dose. J. Clin. Endocrinol. Metab. 95, 1279\u20131287 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2015139_CR114","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/jc.2014-3718","volume":"100","author":"BZ Leder","year":"2015","unstructured":"Leder, B. Z. et al. Effects of abaloparatide, a human parathyroid hormone-related peptide analog, ojennajn bone mineral density in postmenopausal women with osteoporosis. J. Clin. Endocrinol. Metab. 100, 697\u2013706 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2015139_CR115","doi-asserted-by":"publisher","DOI":"10.1210\/endo-meetings.2014.BCHVD.10.OR31-5","volume-title":"Endocrine.org","author":"G Hattersley","year":"2014","unstructured":"Hattersley, G., Dean, T. & Gardella, T. J. Differential binding selectivity of abaloparatide (BA058) compared to PTH and PTHrP type 1 receptor conformations. Endocrine.org [online] (2014)."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2015.139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2015.139","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2015.139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:45:24Z","timestamp":1684453524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2015.139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,25]]},"references-count":115,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["BFnrendo2015139"],"URL":"https:\/\/doi.org\/10.1038\/nrendo.2015.139","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,25]]},"assertion":[{"value":"25 August 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}